Christopher Spires and Laura Lively, Individually and on Behalf of Nolan Spires, A Minor v. St. Francis Medical Center, Marc De Soler, M.D. Amanda Carnes, NNP, and Kathlee Lirette, NNP

CourtLouisiana Court of Appeal
DecidedApril 8, 2026
Docket56,803-CA
StatusPublished
AuthorPitman

This text of Christopher Spires and Laura Lively, Individually and on Behalf of Nolan Spires, A Minor v. St. Francis Medical Center, Marc De Soler, M.D. Amanda Carnes, NNP, and Kathlee Lirette, NNP (Christopher Spires and Laura Lively, Individually and on Behalf of Nolan Spires, A Minor v. St. Francis Medical Center, Marc De Soler, M.D. Amanda Carnes, NNP, and Kathlee Lirette, NNP) is published on Counsel Stack Legal Research, covering Louisiana Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Christopher Spires and Laura Lively, Individually and on Behalf of Nolan Spires, A Minor v. St. Francis Medical Center, Marc De Soler, M.D. Amanda Carnes, NNP, and Kathlee Lirette, NNP, (La. Ct. App. 2026).

Opinion

Judgment rendered April 8, 2026. Application for rehearing may be filed within the delay allowed by Art. 2166, La. C.C.P.

No. 56,803-CA

COURT OF APPEAL SECOND CIRCUIT STATE OF LOUISIANA

*****

CHRISTOPHER SPIRES AND Plaintiffs-Appellants LAURA LIVELY, INDIVIDUALLY AND ON BEHALF OF NOLAN SPIRES, A MINOR versus

ST. FRANCIS MEDICAL CENTER, Defendants-Appellees MARC DE SOLER, M.D. AMANDA CARNES, NNP, AND KATHLEEN LIRETTE, NNP *****

Appealed from the Fourth Judicial District Court for the Parish of Ouachita, Louisiana Trial Court No. 2022-0562

Honorable Frederick D. Jones, Judge

KARL BERNARD LAW, LLC Counsel for Appellants By: G. Karl Bernard

NELSON, ZENTNER, SARTOR, & Counsel for Appellees, SNELLINGS, LLC Amanda Carnes, NNP, By: David H. Nelson and Kathleen Lirette, NNP

HUDSON, POTTS & BERNSTEIN, LLP Counsel for Appellee, By: Gordon L. James Marc de Soler, M.D. Donald H. Zeigler, III

BREAZEALE, SACHSE & WILSON, LLP Counsel for Appellee, By: Thomas Richard Temple, Jr. St. Francis Medical Center Alexa Nicole Candelora

Before PITMAN, STEPHENS, and ROBINSON, JJ. PITMAN, C. J.

Plaintiffs Christopher Spires and Laura Lively, individually and on

behalf of their minor child, Nolan Spires, appeal the summary judgments

granted in this medical malpractice suit in favor of Defendants Marc

De Soler, M.D., Amanda Carnes, NNP, and Kathleen Lirette, NNP. For the

following reasons, we affirm the granting of the summary judgments.

FACTS

Plaintiffs filed suit for medical malpractice against St. Francis

Medical Center (“St. Francis”), Dr. Marc De Soler and nurse practitioners

Amanda Carnes and Kathleen Lirette.

Nolan was born at University Health-Monroe via Cesarean-section at

37 weeks’ gestation on October 11, 2017. His APGAR scores (a rapid, 10-

point assessment of a newborn’s health, calculated at one and five minutes

after birth) were good, 9 and 9 (normal is 7-10), but he subsequently began

developing signs of respiratory distress. He was originally placed on a

Continuous Positive Airway Pressure (CPAP) machine and had acceptable

oxygen saturations, but his distress worsened. He was transferred to the

neonatal intensive care unit at St. Francis.

At St. Francis, Nolan was intubated, and it was discovered that he had

developed a right-sided pneumothorax requiring placement of a chest tube.

His respiratory acidosis eventually resolved, and his blood gases improved.

His distress was diagnosed as a condition called transient tachypnea of the

newborn. On October 12, 2017, Nolan began having seizure-like symptoms,

which lasted for 30 to 45 minutes and continued intermittently. Nurse

practitioner Carnes notified Dr. De Soler, the neonatal medical specialist and

lead physician on his case. Nolan was given Ativan; Cerebyx (Dilantin) and phenobarbital to control the seizure symptoms. He was administered these

drugs at certain intervals with Dr. De Soler testing his toxicity levels several

times. The doctor noted in the discharge summary:

The infant had a phenobarbital level of 33 on 10/14 at 5:30 and had a Dilantin level of 55 on 10/14 at 5:30 a.m., after the infant received a bolus of Cerebyx at 0555 hours, just before obtaining the level. I repeated the Dilantin level at 1300 hours on 10/14, about 8 hours after the bolus was given and it was 69.

Plaintiffs alleged that Dr. De Soler administered the bolus of Cerebyx

prior to receiving the results of the level that had been taken at 5:30 a.m. and

that this mistake caused their son’s resulting damages.1 They claim that

almost immediately after the Cerebyx was administered at 5:55 a.m., Nolan

experienced a sudden hemodynamic deterioration, which resulted in heart

rate readings in the 60s. A Code Blue was called, he was intubated and

required chest compressions, and a needle was inserted into his left chest

without return of air. He was very hypotensive and an EKG was performed,

which revealed a stiff heart with poor relaxation and contraction of the heart.

Bilateral pneumothorax was identified by chest X-ray and tubes were placed.

Plaintiffs claimed that after more than two days of steady decline and failure

of the physician and staff to stabilize him, plans were made to transfer Nolan

to Children’s Hospital of New Orleans, a facility which could provide a

higher level of care. However, when the crew arrived to transfer him, Nolan

was too unstable to be immediately transported.

1 The results of the test were not available until 7:14 a.m. The medical review panel addressed this issue in its report, noted the time of the testing and the administration of the bolus of Cerebyx, and stated, “To expect the lab work report on Dilantin to be returned quickly is unreasonable. The Dilantin level of 55.8 was reported at 7:14 am. The evidence indicates Dr. De Soler was notified promptly and discontinued the Cerebyx. Prior to this, the infant had a cardiac respiratory arrest, which was managed appropriately. Subsequent Dilantin level showed an increase to 69.8. The evidence supports Dr. De Soler’s efforts to determine the etiology of the high rise of levels, including metabolism disorder.” 2 When he ultimately arrived in New Orleans on October 15, 2017, it

was discovered that Nolan was suffering from Dilantin toxicity, and

appropriate treatment began. Nolan remained in New Orleans until

December 2, 2017. During his stay, he required several interventions,

including an extracorporeal membrane oxygenation (ECMO) procedure to

serve as a bypass for a poorly functioning circulatory and respiratory system.

Plaintiffs assert that Nolan now suffers with developmental, cognitive,

motor, speech and social/behavioral delays. He cannot understand

nonverbal communications, walk or use the restroom independently and has

bouts of emotional distress and other deficits.

Following the filing of Plaintiffs’ original medical malpractice claim

against Defendants, the medical review panel (“MRP”) published its opinion

entitled, “Opinion and Written Reasons for Conclusion.” A case report

attached to the MRP’s written reasons is in the original record of this suit

and is entitled, “Cardia Collapse Secondary to Phenytoin Toxicity in a

Neonate Treated with Extracorporeal Membrane Oxygenation Support.”

Plaintiffs alleged that this report is based on Nolan’s medical history and

was published in the Journal of Medical Toxicology in November 2019.2 It

found that although medication overdose and toxicity are uncommon in

neonates, some medications pose a risk. One of those is Fosphenytoin,

which is sold under the name Cerebyx.

The MRP found that the evidence presented supported the conclusion

that St. Francis and its staff, particularly the pharmacy staff, failed to meet

2 Defendants alleged that the case study, while attached to the MRP’s written opinion and seeming to be exactly descriptive of Nolan’s case, never mentions him by name. This was not an issue until the case was later appealed to this court after rendition of the reconsideration of the summary judgment at issue in this appeal. 3 the applicable standard of care as charged in the complaint and that the

conduct complained of was a factor in the resulting damages. Specifically,

the MRP stated that the pharmacy staff of St. Francis failed particularly in

the preparation of the dose and delivery of the Cerebyx, which was

“inappropriate and incorrect, leading to the Dilantin toxicity and level

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Samaha v. Rau
977 So. 2d 880 (Supreme Court of Louisiana, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Christopher Spires and Laura Lively, Individually and on Behalf of Nolan Spires, A Minor v. St. Francis Medical Center, Marc De Soler, M.D. Amanda Carnes, NNP, and Kathlee Lirette, NNP, Counsel Stack Legal Research, https://law.counselstack.com/opinion/christopher-spires-and-laura-lively-individually-and-on-behalf-of-nolan-lactapp-2026.